COBIK

Executive Summary

COBIK is a Slovenian biotechnology company founded in 2009 and operating as a Center of Excellence for Biosensors, Instrumentation, and Process Control. The company provides bioprocess development, non-GMP manufacturing, and project management services to both the biopharma industry and academia. Additionally, COBIK maintains an internal R&D pipeline focused on developing bacteriophage-based antibacterial therapies and viral vaccines. Despite its service-oriented business model, the company’s proprietary pipeline remains at an early stage, with no publicly disclosed clinical candidates or partnerships. COBIK's dual focus on service revenue and internal discovery positions it as a niche player in the European biotech landscape, though its pipeline visibility is limited.

Upcoming Catalysts (preview)

• TBDAdvancement of Phage Therapy Lead Candidate to Preclinical Testing30% success
• TBDNew Service Contract with Major Biopharma or Academic Partner50% success
• TBDViral Vaccine Program Reaches Investigational New Drug (IND) Filing Stage20% success